Monrovia, CA -- (SBWIRE) -- 06/18/2011 -- Martyn Banks, Ph.D., Executive Director, Molecular Sciences and Candidate Optimization, Bristol Myers Squibb, will give a featured presentation titled “The Impact of Screening on Drug Discovery at Bristol Myers Squibb” at GTC’s 6th Assay & Drug Discovery Technologies Conference on July 7-8, 2011 in San Francisco, CA.

Dr. Banks will highlight how this screening success was achieved from a scientific, technological and most importantly the cultural perspective. Each of these domains of success will be described and the talk will focus on examples of success and lessons learned. The talk will also describe small vignettes from compounds that are in clinical trials or those that are now used to treat patients. The audience will hear how not only innovative science was enabled but how the complex interplay of drug discovery disciplines worked together toward a common goal with a holistic approach to the use of technology.

GTC’s Ocular Diseases 6th Assay & Drug Discovery Technologies conference will also have keynote speaker, George P. Hemstreet, III, Chief of Urologic Surgery at University of Nebraska Medical Center and featured speaker Ilona Kariv, Director and Lead of In Vitro and Cellular Pharmacology at Merck Research Laboratories. This event will bring together leaders from Abbott, Pfizer, Novartis, Roche Discovery Technologies, Genentech, GE Healthcare and other cutting-edge biotech, academic and government organizations to present innovative and relevant applications of current screening technologies.

GTC’s 6th Assay & Drug Discovery Technologies Conference will provide cutting edge information and a chance to exchange ideas from leading experts in the field. For more information, please visit: http://www.gtcbio.com/component/conference/?file=home&cn=6th+Assay&cid=31.